What is the level of liabilities of Hisamitsu Pharmaceutical Co this year?
Hisamitsu Pharmaceutical Co has a debt balance of 63.9 B JPY this year.
Hisamitsu Pharmaceutical Co Liabilities 2024
Hisamitsu Pharmaceutical Co Liabilities
63.9 B JPY
Ticker
4530.T
ISIN
JP3784600003
WKN
864341
In 2024, Hisamitsu Pharmaceutical Co's total liabilities amounted to 63.9 B JPY, a 28.6% difference from the 49.69 B JPY total liabilities in the previous year.
Hisamitsu Pharmaceutical Co Aktienanalyse
What does Hisamitsu Pharmaceutical Co do?
Hisamitsu Pharmaceutical Co Inc is a Japanese company that was founded in 1847. The company is known for its patches and other medical products, making it one of the largest pharmaceutical manufacturers in Japan. The company specializes in the development and production of pharmaceuticals, medical devices, and health and beauty products. They have four main business areas: pharmaceutical products, health products, medical devices, and cosmetics. In addition to their popular Salonpas patches, they also offer a range of other medications, health products, medical devices, and cosmetics. Hisamitsu is committed to improving health and well-being through innovation and collaboration with research institutions and universities. Hisamitsu Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Hisamitsu Pharmaceutical Co's Liabilities
Hisamitsu Pharmaceutical Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Hisamitsu Pharmaceutical Co's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Hisamitsu Pharmaceutical Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Hisamitsu Pharmaceutical Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Hisamitsu Pharmaceutical Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Hisamitsu Pharmaceutical Co stock
What were the liabilities of Hisamitsu Pharmaceutical Co compared to the previous year?
The liabilities of Hisamitsu Pharmaceutical Co have increased by 28.6% increased compared to the previous year.
What are the consequences of high debt for investors of Hisamitsu Pharmaceutical Co?
High liabilities can pose a risk for investors of Hisamitsu Pharmaceutical Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Hisamitsu Pharmaceutical Co?
Low liabilities mean that Hisamitsu Pharmaceutical Co has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Hisamitsu Pharmaceutical Co affect the company?
An increase in liabilities of Hisamitsu Pharmaceutical Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Hisamitsu Pharmaceutical Co affect the company?
A decrease in the liabilities of Hisamitsu Pharmaceutical Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Hisamitsu Pharmaceutical Co?
Some factors that can influence the liabilities of Hisamitsu Pharmaceutical Co include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Hisamitsu Pharmaceutical Co so important for investors?
The liabilities of Hisamitsu Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Hisamitsu Pharmaceutical Co take to modify the liabilities?
To change its liabilities, Hisamitsu Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Hisamitsu Pharmaceutical Co pay?
Over the past 12 months, Hisamitsu Pharmaceutical Co paid a dividend of 44.5 JPY . This corresponds to a dividend yield of about 1.1 %. For the coming 12 months, Hisamitsu Pharmaceutical Co is expected to pay a dividend of 45.42 JPY.
What is the dividend yield of Hisamitsu Pharmaceutical Co?
The current dividend yield of Hisamitsu Pharmaceutical Co is 1.1 %.
When does Hisamitsu Pharmaceutical Co pay dividends?
Hisamitsu Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of September, March, September, March.
How secure is the dividend of Hisamitsu Pharmaceutical Co?
Hisamitsu Pharmaceutical Co paid dividends every year for the past 23 years.
What is the dividend of Hisamitsu Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 45.42 JPY are expected. This corresponds to a dividend yield of 1.12 %.
In which sector is Hisamitsu Pharmaceutical Co located?
Hisamitsu Pharmaceutical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Hisamitsu Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Hisamitsu Pharmaceutical Co from 11/1/2024 amounting to 2 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.
When did Hisamitsu Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 11/1/2024.
What was the dividend of Hisamitsu Pharmaceutical Co in the year 2023?
In the year 2023, Hisamitsu Pharmaceutical Co distributed 42.75 JPY as dividends.
In which currency does Hisamitsu Pharmaceutical Co pay out the dividend?
The dividends of Hisamitsu Pharmaceutical Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Hisamitsu Pharmaceutical Co
Our stock analysis for Hisamitsu Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hisamitsu Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Hisamitsu Pharmaceutical Co Revenue
- Hisamitsu Pharmaceutical Co Net Income
- Hisamitsu Pharmaceutical Co P/E
- Hisamitsu Pharmaceutical Co P/S
- Hisamitsu Pharmaceutical Co EBIT
- Hisamitsu Pharmaceutical Co Dividend
- Hisamitsu Pharmaceutical Co Stocks
- Hisamitsu Pharmaceutical Co Market capitalization
- Hisamitsu Pharmaceutical Co Debt
- Hisamitsu Pharmaceutical Co Liabilities
- Hisamitsu Pharmaceutical Co Equity
- Hisamitsu Pharmaceutical Co AAQS
- Hisamitsu Pharmaceutical Co Employees
- Hisamitsu Pharmaceutical Co ROE
- Hisamitsu Pharmaceutical Co ROA
- Hisamitsu Pharmaceutical Co ROCE
